Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;2(6):440-454.
doi: 10.1016/S2352-4642(18)30066-X. Epub 2018 Mar 30.

Global efforts toward the cure of childhood acute lymphoblastic leukaemia

Ching-Hon Pui  1 , Jun J Yang  2 , Nickhill Bhakta  3 , Carlos Rodriguez-Galindo  3
Affiliations
Review

Global efforts toward the cure of childhood acute lymphoblastic leukaemia

Ching-Hon Pui et al. Lancet Child Adolesc Health. 2018 Jun.

Erratum in

Abstract

Improvements in risk-directed treatment and supportive care, together with increased reliance on both national and international collaborative studies, have made childhood acute lymphoblastic leukaemia (ALL) one of the most curable human cancers. Next-generation sequencing studies of leukaemia cells and the host germline provide new opportunities for precision medicine and thus potential improvements in the cure rate and quality of life of patients. Efforts are underway to assess the global impact of childhood ALL and develop initiatives that can meet the long-term challenge of providing quality care to children with this disease worldwide and improving cure rates globally. This ambitious task will rely on increased collaborative research and international networking so that the therapeutic gains in high-income countries can be translated to patients in low-income and middle-income countries. Ultimately, the greatest obstacle to overcome will be to fully understand leukaemogenesis, enabling measures to decrease the risk of leukaemia development and thus close the last major gap in offering a cure to any child who might have the disease.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests

The authors declared no conflicts of interest.

Figures

Figure 1.
Figure 1.. Global variation in the frequency of key genetic variants associated with ALL susceptibility and treatment toxicities.
Numbers in parentheses denote the percentage of individuals with the risk allele.
See this image and copyright information in PMC

References

    1. Pui CH, Evans WE. A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol 2013; 50(3): 185–96. - PMC - PubMed
    1. Moricke A, Zimmermann M, Valsecchi MG, et al. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood 2016; 127(17): 2101–12. - PubMed
    1. Escherich G, Zimmermann M, Janka-Schaub G, Co ALLsg. Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07–03. Pediatr Blood Cancer 2013; 60(2): 254–7. - PubMed
    1. Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol 2012; 30(14): 1663–9. - PMC - PubMed
    1. Pieters R, Groot-Kruseman Hd, Velden VVd, et al. Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group. Journal of Clinical Oncology 2016; 34(22): 2591–601. - PubMed

Publication types

LinkOut - more resources